[Efficacy and tolerability of a clopidogrel desensitization protocol].
Anna
A
Estefanell-Tejero
Carmen
C
López-Cabezas
Gisela
G
Riu-Viladoms
Carlos
C
Falces-Salvador
D000368:Aged; D000369:Aged, 80 and over; D000077144:Clopidogrel; D003888:Desensitization, Immunologic / Q000379:methods*; D003875:Drug Eruptions / Q000276:immunology / Q000517:prevention & control; D004342:Drug Hypersensitivity / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000276:immunology*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine